about
Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic diseaseTransmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinomaProstatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epitheliumA C-14 labeled Py-Im polyamide localizes to a subcutaneous prostate cancer tumor.Molecular markers and determinants of prostate cancer metastasis.Second harmonic microscopic imaging and spectroscopic characterization in prostate pathological tissue.Prostatic intraepithelial neoplasia in genetically engineered miceTrials, tribulations, and trends in tumor modeling in mice.Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue.Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate modelExpression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer.Linneg Sca-1high CD49fhigh prostate cancer cells derived from the Hi-Myc mouse model are tumor-initiating cells with basal-epithelial characteristics and differentiation potential in vitro and in vivo.ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.2,3,7,8-Tetrachlorodibenzo-p-dioxin has both pro-carcinogenic and anti-carcinogenic effects on neuroendocrine prostate carcinoma formation in TRAMP mice.Metastasizing neuroblastomas from taste buds in rats transgenic for the Simian virus 40 large T antigen under control of the probasin gene promoter.Effects of genetic background on prostate and taste bud carcinogenesis due to SV40 T antigen expression under probasin gene promoter control.Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancerInduction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia
P2860
Q26827629-03EF978B-2075-4174-A2D9-BC538C399AE6Q27308107-C6FCF9D2-ACE2-4EDD-B118-7E4447A29210Q28508802-980D3590-21E3-488E-B63B-82AEF364906CQ34053649-5533890B-7AD3-432E-806A-8BD69AB4C388Q34465689-2F365399-D270-4944-800E-FC9AEB8C41D5Q34897758-7652F7F5-7274-4C9E-AA5D-3AFCE8D003A0Q35747658-857049A4-3BAF-49FD-BEC3-6AF0C048058BQ35812510-3C7B848E-3779-4F60-8903-EAB84CE47F86Q37304966-43DC15A9-9D9A-4253-A6EE-54638F043A09Q37365555-D5F668C4-0FA6-48A1-91DC-7918F6EFF592Q37616570-046E5E98-C6D2-4FC4-82A8-FAB242F8FEB7Q38791434-1760497D-7BC2-45C5-8C1D-D770DA5C23BFQ42049451-0A7FC6D8-612A-4F07-B8AA-73E2BCB07B42Q42360795-DB2ABB72-3380-49E6-BC3A-BE4B4C99994FQ43665417-F587E474-2357-491B-B0BD-829BA841CEB7Q43918577-DB950BC5-783A-4F39-BE4A-2042E0FD0C8AQ45856252-06E652AE-A309-4311-9501-9840DCFA72AFQ56892940-F501BDED-E35E-4A53-AE38-5D3633B5C022Q58236963-99029DE1-2B79-4AB5-8E3F-F24520C22C01
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mouse models of prostate cancer.
@ast
Mouse models of prostate cancer.
@en
type
label
Mouse models of prostate cancer.
@ast
Mouse models of prostate cancer.
@en
prefLabel
Mouse models of prostate cancer.
@ast
Mouse models of prostate cancer.
@en
P2860
P356
P1433
P1476
Mouse models of prostate cancer.
@en
P2093
Schreiber-Agus N
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203037
P407
P577
1999-09-01T00:00:00Z
P5875
P6179
1023587527